Literature DB >> 1893369

Acquired immunodeficiency syndrome and non-Hodgkin's lymphomas.

J E Karp1, S Broder.   

Abstract

Entities:  

Mesh:

Year:  1991        PMID: 1893369

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  10 in total

1.  CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation.

Authors:  S Nikiforow; K Bottomly; G Miller
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Inhibition of Fas-mediated apoptosis by antigen: implications for lymphomagenesis.

Authors:  Elaine J Schattner; Steven M Friedman; Paolo Casali
Journal:  Autoimmunity       Date:  2002-07       Impact factor: 2.815

3.  Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-kappaB activity.

Authors:  W Chen; N R Cooper
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

4.  Enhanced tumorigenicity of an Epstein-Barr virus-transformed lymphoblastoid cell line is associated with a unique 1:18 chromosomal translocation and decreased expression of lymphocyte function associated antigen-1a (CD11A).

Authors:  G R Picchio; J I Cohen; E R Wyatt; D E Mosier
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

Review 5.  Molecular pathology of AIDS-related lymphomas. Biologic aspects and clinicopathologic heterogeneity.

Authors:  G Gaidano; C Pastore; C Lanza; U Mazza; G Saglio
Journal:  Ann Hematol       Date:  1994-12       Impact factor: 3.673

6.  Immunohistochemical analysis of p53 expression in malignant lymphomas.

Authors:  J W Said; R Barrera; I P Shintaku; H Nakamura; H P Koeffler
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

7.  Low expression of CD20 and CD23 in Epstein-Barr virus-induced B cell tumors in SCID/hu mice.

Authors:  J L Garnier; N R Cooper; M J Cannon
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

8.  Cytolytic CD4(+)-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferation.

Authors:  Sarah Nikiforow; Kim Bottomly; George Miller; Christian Münz
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  DNA cell cycle distribution and glutathione (GSH) content according to circadian stage in bone marrow of cancer patients.

Authors:  R Smaaland; J F Abrahamsen; A M Svardal; K Lote; P M Ueland
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

10.  The epidemiology of AIDS-associated non-Hodgkin's lymphoma in the World Health Organization European Region.

Authors:  D Serraino; G Salamina; S Franceschi; D Dubois; C La Vecchia; J B Brunet; R A Ancelle-Park
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.